Product Overview

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: LevoCept is an IUD product. It consists of a flexible shape memory frame and a reservoir containing 52 mg of levonorgestrel.

Updated date: May 30, 2018

Vertical Tabs


Project Phase: Late Development

Project Stage: Phase II

Status Details:
  • Phase 2 clinical study to evaluate the effectiveness, safety and tolerability of LevoCept began in the US in November, 2016 with estimated study completion in April, 2021.

Download Product Report